Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Non Operating Income: 2017-2025

Historic Non Operating Income for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $433,000.

  • Organogenesis Holdings' Non Operating Income rose 203.34% to $433,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 204.17%. This contributed to the annual value of -$1.5 million for FY2024, which is 28.55% up from last year.
  • Latest data reveals that Organogenesis Holdings reported Non Operating Income of $433,000 as of Q3 2025, which was down 41.64% from $742,000 recorded in Q2 2025.
  • Organogenesis Holdings' Non Operating Income's 5-year high stood at $963,000 during Q1 2025, with a 5-year trough of -$3.4 million in Q3 2021.
  • In the last 3 years, Organogenesis Holdings' Non Operating Income had a median value of -$419,000 in 2024 and averaged -$138,000.
  • As far as peak fluctuations go, Organogenesis Holdings' Non Operating Income crashed by 1,563.89% in 2023, and later skyrocketed by 296.13% in 2025.
  • Over the past 5 years, Organogenesis Holdings' Non Operating Income (Quarterly) stood at -$862,000 in 2021, then surged by 104.18% to $36,000 in 2022, then slumped by 1,563.89% to -$527,000 in 2023, then surged by 106.45% to $34,000 in 2024, then spiked by 203.34% to $433,000 in 2025.
  • Its Non Operating Income was $433,000 in Q3 2025, compared to $742,000 in Q2 2025 and $963,000 in Q1 2025.